Congratulations to the Emblem team on making it to the semi-finals in the Versalie Innovation Challenge!
Excited to announce that we've made it to the semi-finals of the Versalie™ Innovation Challenge!
Located in San Francisco CA, TheraNova is a medical device development company focused on developing solutions to large markets with unmet needs. TheraNova accomplishes this through its mission to improve outcomes, decrease costs and expand access to healthcare.
External link for Theranova, LLC
101 Mississippi Street
Suite 100
San Francisco, CA 94107, US
🌟 Exciting news from Piccolo Medical, Inc! They've just received FDA clearance for their ECGuide™ Catheter Guidance Technology. 🎉 A huge congratulations to the team on this major milestone in advancing medical technology! #Innovation #MedTech #Startups #HealthcareTech
Congratulations to the Emblem Systems team, a Theranova portfolio company, on their innovative achievement! They have developed a simple, at-home AI-based technology for quantifying menstrual blood loss. This breakthrough will empower individuals with a convenient tool for tracking their health. Kudos to the team for their dedication to advancing healthcare accessibility and convenience. #HealthTech #Innovation #EmblemSystems #Theranova #AITechnology #MenstrualHealth https://lnkd.in/gSvwPHp2
At Emblem we're using AI to quantify menstrual blood loss. 🔴 🎉 We're excited to share that Emblem was featured at this year's Femtech Fes, the premier event for women's health technology in Japan, hosted by fermata, Inc.! Our Product Manager, Ana Cachau-Hansgardh, presented our revolutionary technology alongside other innovative FemTech solutions, empowering women to take control of their reproductive health. 🙏 Huge thanks to Amina Sugimoto, Lia Camargo, Kotone Nakamatsu and the whole fermata team for providing a platform to showcase our technology. We're proud to drive progress in women's health. Stay tuned! #FemtechFes #WomensHealth #EmblemSystem
Congratulations to the entire Gravitas Team. What a huge success! https://lnkd.in/gW2KQcgQ
PEDIATRIC BREAKTHROUGH!! Gravitas Medical has been granted its second FDA Breakthrough Device Designation of 2023 with pediatric applications joining the neonatal designation announced this past September. Breakthrough Device Designation is granted to medical devices that enhance the treatment or diagnosis of life-threatening or irreversibly debilitating medical conditions for which no FDA approved alternatives exist. This announcement further validates the innovative approach Gravitas Medical is introducing for data-driven enteral nutrition management. “We remain focused on rapidly expanding the Entarik platform to include use with neonatal and pediatric patients". Jorgen B. Hansen, CEO - Gravitas Medical https://lnkd.in/dT_VCCXg
Big news for postmenopausal women! Bone Health Technologies has just received FDA approval for the first non-pharmacological prescription treatment for low bone density. It's also the first FDA-approved early intervention treatment for osteopenia. Check out the link for more information and share. #osteoporosis #osteopenia #medtech #womenshealth #menopause https://lnkd.in/gQNwzx37